Back to stocks
ANIP

ANIP

ANI Pharmaceuticals, Inc.

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
17
Partial Q3 2026
Total 13F value
$6.3M
Filed positions so far
New positions
2
This quarter
Sold positions
4
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Oliver Luxxe Assets Llc

$1.6M22.5K0.26%-5.2%

Artemis Investment Management Llp

$1.5M20.4K0.01%-27.7%

Wedge Capital Management L L P/Nc

$1.4M19.3K0.02%-0.3%

Assenagon Asset Management S.A.

$1.2M15.9K0.00%Unchanged

State Of Alaska, Department Of Revenue

$326K4.5K0.00%-39.0%

Gamma Investing Llc

$130K1.8K0.00%+13.4%

Nfsg Corp

$44K6000.01%Unchanged

Usa Financial Formulas

$39K5370.01%New Position

Versant Capital Management, Inc

$31K4270.00%+103.3%

Farther Finance Advisors, Llc

$10K1350.00%+27.4%

Fortitude Family Office, Llc

$9K1270.00%+1487.5%

Massmutual Private Wealth & Trust, Fsb

$8K1110.00%-16.5%

Mather Group, Llc.

$2K310.00%Unchanged

Essential Partners Llc

$21830.00%Unchanged

Cedar Mountain Advisors, Llc

$21830.00%New Position

Gilpin Wealth Management, Llc

$14620.00%Unchanged

Ifp Advisors, Inc

$7310.00%Unchanged

Explore